'We need to choose a vaccine that is most suitable to our current circumstance'
Issues we still have around HIV/Aids treatment
We have to protect the credibility of these examinations - Umalusi
'Nelson Mandela Bay COVID-19 restrictions to provide reprieve to health workers'
Govt looking to raise $400 million from sale of stake in bankrupt SAA - report
'History will absolve us' - Former Eskom exec Matshela Koko at Zondo Commission
When it comes to funding, IDC keeps shifting goal posts - bemoans entrepreneur
Govt pension fund recovers from March year-end loss, assets at R1.9 trillion
Keen hiker, Azania Mosaka conquers the Otter Trail
Local celebrity platform myFanPark extends global reach with US merger
'There's been no consultation' - Rasa will fight any stricter Covid restrictions
Diego Maradona left no will – family wants his £150m but lawyer says he was poor
Pitso Mosimane bags second CAF Champions League title
[BREAKING] Soccer legend Diego Maradona passes away
[WATCH] Beautiful collaboration between P!nk and Ndlovu Youth Choir goes viral
[WATCH] Two men saving turtle from jaws of tiger shark goes viral
Sello Maake ka-Ncube: There is no respect for actors in the industry
Here's how you can donate to 702''s charitable toy drive 'Toys For Joy'
Local brewer of agave spirits aiming to change SA culture around tequila
Boosting wine tourism: Netflix film to star Cape Winelands as travel destination
Take heart – African financial markets are innovating, the pandemic shows
Bushiri will return to SA once he is sure of his safety and security - Lawyer
'Bushiris to appear in Lilongwe court this afternoon,' says Malawian journalist
Don't Worry, Be Merry: 'Checkers Xmas ad may be corny, but gets under your skin'
50 people who royally 'stuffed' up our fine, glorious land - Alexander Parker
Aspen Pharmacare shares up 11% on Covid-19 vaccine deal with Johnson & Johnson
JSE-listed Aspen Pharmacare has struck a deal with US multinational Johnson & Johnson to commercially manufacture its vaccine candidate.
Johnson & Johnson’s “Ad26.COV2-S” vaccine is undergoing clinical trials.
Aspen Pharmacare will make the vaccines at an existing factory in Port Elizabeth if trials are successful and manufacturing terms are finalised.
The facility is capable of making 300 million vaccine doses per year.
Aspen Pharmacare’s share price was up 11.45% on Monday.
The Money Show’s Bruce Whitfield interviewed Stephen Saad, CEO at Aspen Pharmacare.
Johnson & Johnson’s is a $400 billion company… We’re well-positioned… The tech transfer – we’ve started the process…
Stephen Saad, CEO - Aspen Pharmacare
Johnson & Johnson… we like their candidate. You only need one shot… and a fridge… They’ve got 60 000 people in their Phase-3 trial…
Stephen Saad, CEO - Aspen Pharmacare
Johnson & Johnson promised universal access…
Stephen Saad, CEO - Aspen Pharmacare
We’ll be ready to put a vaccine into the world by March or April next year…
Stephen Saad, CEO - Aspen Pharmacare
Listen to the interview in the audio below.
This article first appeared on CapeTalk : Aspen Pharmacare shares up 11% on Covid-19 vaccine deal with Johnson & Johnson
More from MyMoney Online
Naspers-owned Prosus (owner of Tencent) starts JSE's largest share buyback ever
The Money Show’s Bruce Whitfield interviews Basil Sgourdos, CFO at Naspers.
Read More
Pepkor Holdings profits fall 34% but gains 'significant' market share
The Money Show’s Bruce Whitfield interviews Leon Lourens, CEO at Pepkor Holdings.
Read More
Netcare profits hit by Covid-19. Embarks on a job preservation strategy
The Money Show’s Bruce Whitfield interviews Dr Richard Friedland, CEO at Netcare.
Read More
Make your retirement savings last longer
Personal finance advisor Warren Ingram on ensuring you don’t run out of money before you run out of life.
Read More
How to have many sources of income – not just your salary
From side hustles to investment income; Mduduzi Luthuli (Luthuli Capital) on creating multiple streams of income.
Read More
We buy stuff we don’t need to impress people we don’t know
What is "social signalling?" Gushwell Brooks interviews Mduduzi Luthuli, a cofounder at Luthuli Capital.
Read More
Prescribed assets: Magda Wierzycka (CEO, Sygnia) accuses IRR of bullying her
"What the IRR is doing is not in the best interest of the savers of SA," Wierzycka told The Money Show's Bruce Whitfield.
Read More
Just choose Tencent! – this and other investment tips from David Shapiro
Veteran stockbroker David Shapiro schools The Money Show’s Bruce Whitfield on investing post-Covid and into the next few years.
Read More
How to secure your retirement - Bruce Cameron (retired editor, Personal Finance)
Bruce Cameron discusses with Bruce Whitfield his new book on securing your retirement, despite corruption and the smashed economy.
Read More
Long-term investment case for property in Africa remains intact
There’ll be many opportunities for frontier investors in the coming years, says Absa's Somaya Joshua.
Read MoreMore from Covid-19 coronavirus explained
Pfizer’s Covid-19 vaccine is extremely effective (90%)
Pfizer is on the verge of cracking a Covid-19 vaccine, says Dr Glenda Gray, CEO at Medical Research Council.
Read More
'Emigration is threatening private healthcare in South Africa'
"The insured population is potentially emigrating," says Jessica Spira. But, the main concern is healthcare workers leaving.
Read More
[BOOK REVIEW] The future arrived early - economist Dr Iraj Abedian
Famed economist Dr Iraj Abedian talks about his book, "FutureNEXT: Reimagining Our World and Conquering Uncertainty”.
Read More
Middleclass incomes have recovered almost fully since hard lockdown – FNB data
The lowest and highest-paid workers in SA haven’t yet recovered from the lockdown, according to FNB's Dr Christoph Nieuwoudt.
Read More
Famous Brands (owner of Steers/Wimpy/etc.) reports its 1st ever operating loss
The Money Show’s Bruce Whitfield interviews Famous Brands CEO Darren Hele.
Read More
'Another hard lockdown will cause even more state violence'
Futurist Graeme Codrington and economist Dick Forslund on how a 2nd hard lockdown and a 2nd Covid wave might affect our country.
Read More
Money lessons Covid-19 taught – heed them for a brighter, wealthier future
Your financial future – even if you have to start over – could be brighter than it would’ve been without the pandemic.
Read More
Covid-19 resurgence in Europe smashes South African rand off its pedestal
The rand was just recently trading at a six-month high. Arabile Gumede interviews Bianca Botes (Peregrine Treasury Solutions).
Read More
Open South Africa’s borders, please! - once-prospering tourism industry
Bruce Whitfield interviews tourism consultant Gillian Saunders, a previous advisor to former Tourism Minister Derek Hanekom.
Read More
Does Govt have a plan to fix our lockdown-smashed, drowning-in-debt country?
The Money Show’s Bruce Whitfield interviews Duma Gqubule, founder at the Centre for Economic Development and Transformation.
Read MoreMore from Information about Covid-19 coronavirus
Pfizer’s Covid-19 vaccine is extremely effective (90%)
Pfizer is on the verge of cracking a Covid-19 vaccine, says Dr Glenda Gray, CEO at Medical Research Council.
Read More
'Emigration is threatening private healthcare in South Africa'
"The insured population is potentially emigrating," says Jessica Spira. But, the main concern is healthcare workers leaving.
Read More
Middleclass incomes have recovered almost fully since hard lockdown – FNB data
The lowest and highest-paid workers in SA haven’t yet recovered from the lockdown, according to FNB's Dr Christoph Nieuwoudt.
Read More
Famous Brands (owner of Steers/Wimpy/etc.) reports its 1st ever operating loss
The Money Show’s Bruce Whitfield interviews Famous Brands CEO Darren Hele.
Read More
'Another hard lockdown will cause even more state violence'
Futurist Graeme Codrington and economist Dick Forslund on how a 2nd hard lockdown and a 2nd Covid wave might affect our country.
Read More
'We need to stick to COVID-19 health protocols so that we avoid a second wave'
Social Development minister Lindiwe Zulu reflects on the concerning rise of the coronavirus infections.
Read More
UPDATE: SA COVID-19 recovery rate reaches 90%
There were 15,028 new tests conducted and 22 new coronavirus-related deaths. New infections were 1.268.
Read More
Money lessons Covid-19 taught – heed them for a brighter, wealthier future
Your financial future – even if you have to start over – could be brighter than it would’ve been without the pandemic.
Read More
Covid-19 resurgence in Europe smashes South African rand off its pedestal
The rand was just recently trading at a six-month high. Arabile Gumede interviews Bianca Botes (Peregrine Treasury Solutions).
Read More
Open South Africa’s borders, please! - once-prospering tourism industry
Bruce Whitfield interviews tourism consultant Gillian Saunders, a previous advisor to former Tourism Minister Derek Hanekom.
Read More
Highlights